Echo Therapeutics, Inc. — Form D

Echo Therapeutics, Inc. of Iselin, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-19. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Robert DomanDirectorPhiladelphia, PA
Vincent EnrightDirectorPhiladelphia, PA
William GriecoDirectorAustin, TX
James SmithDirectorParker, CO
Kimberly BurkeExecutive OfficerPhiladelphia, PA
Robert DomanExecutive OfficerPhiladelphia, PA
Christopher SchnittkerExecutive OfficerCarneys Point, NJ
Vincent D EnrightDirectorRye, NY
Robert LangerDirectorPittsburgh, PA
Patrick T MooneyDirectorHaddonfield, NJ
Patrick T MooneyExecutive OfficerHaddonfield, NJ
Patrick MooneyDirectorHaddonfield, NJ
Patrick MooneyExecutive OfficerHaddonfield, NJ
Shawn SinghDirectorHouston, TX
Shawn K SinghDirectorSouth San Francisco, CA
Walter WitoshkinDirectorSan Francisco, CA
Scott W HollanderDirectorIselin, NJ
Scott W HollanderExecutive OfficerIselin, NJ
Alan W SchoenbartExecutive OfficerIselin, NJ
Michael M GoldbergDirectorIselin, NJ
Shepard M GoldbergDirectorIselin, NJ
James F SmithDirectorBellevue, NE
WILLIAM F GRIECODirectorFRANKLIN, MA
HARRY G MITCHELLExecutive OfficerFRANKLIN, MA
HARRY MITCHELLExecutive OfficerFRANKLIN, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2016-02-08D$6.0M$1.8M
2011-02-15D$3.5M$3.5M
2011-02-15D/A$3.0M$2.9M
2010-11-05D$3.0M
2010-10-21D$5.0M$2.5M
2009-12-07D$563K$563K
2009-11-20D$3.6M$3.0M
2009-07-28D$2.0M$2.0M

More